A 5-day course of ivermectin was put to the test in Dhaka, Bangladesh. A randomized, double-blind, placebo-controlled trial was set up to study the safety and effectiveness of ivermectin on mild respiratory infection. The results were clear: Ivermectin hastens patient recovery, speeding up virological clearance. Patients who took the 5-day course of ivermectin recovered three days faster than the placebo group.
The symptoms cleared up faster for the ivermectin group (9.7 days), compared to both the ivermectin plus doxycycline group (11.5 days) and the placebo group (12.7 days). Larger clinical trials can help confirm ivermectin as a safe intervention to speed up recovery from respiratory illnesses associated with SARS-CoV-2.A 5-day course of ivermectin hastens patient recovery from respiratory infection – real-world study – Dr. Eddy Bettermann MD